BIIB Trading Analysis - 09/10/2026 04:33 PM โ€” TRU-SENTIMENT

BIIB (Biogen Inc. Common Stock) at $215.43. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $1,908,780 vs put $12,210. RSI 51.4.

TRU-SENTIMENT ยท DeltaNeutral

BIIB Trading Analysis - 09/10/2026 04:33 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

BIIB (Biogen Inc. Common Stock) at $215.43. True Sentiment Bullish, delta 40-60 call 99% / put 1%, call $1,908,780 vs put $12,210. RSI 51.4.

Symbol
BIIB
Price
$215.43
Article bias (separate from True Sentiment)
neutral
Conviction
medium
Published
2026-09-10 16:33:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume:

  • Call dollar volume: $1,908,780
  • Put dollar volume: $12,210

The options flow sentiment is strongly bullish, indicating a positive outlook for the stock.

Key Statistics: BIIB

$210.73 +0.00%
52-Week Range
$135.39 - $225.80
Market Cap
$93.67B
P/E (TTM)
37.43
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$1.44M
Dividend Yield
N/A

Fundamental Snapshot

Valuation

P/E (Trailing)37.43
P/E (Forward)N/A
PEG RatioN/A
Price/Book4.97

Profitability

EPS (Trailing)$5.63
EPS (Forward)N/A
ROE4.43%
Net Margin8.32%

Financial Health

Revenue (TTM)$10.03B
Debt/Equity0.39
Free Cash FlowN/A
Rev GrowthN/A

Analyst Consensus

None
Target: $N/A
Based on None Analysts

๐Ÿ“ˆ Analysis

News Headlines & Context:

Recent news headlines for BIIB include:

  • Insider Buying: BIIB's executive vice president, Jeffrey H. Coplan, purchased 5,000 shares on September 8, 2026.
  • BIIB's competitor, Cigna Group (CI), reported better-than-expected Q2 earnings on August 5, 2026.
  • Bluebird Bio (BIRD) announced positive results from its Phase 3 trial for a sickle cell disease treatment on September 1, 2026.

These headlines suggest that there is increased insider buying activity and positive developments in the biotech sector, which could have a positive impact on BIIB's stock price.

Fundamental Analysis:

Based on the provided fundamentals data:

  • Revenue: $10,027,900,000
  • Trailing EPS: $5.63
  • Trailing P/E: 37.43
  • Price-to-Book: 4.97
  • Debt-to-Equity: 0.39
  • Return on Equity (ROE): 4.43%
  • Gross Margin: 73.99%
  • Operating Margin: 10.09%
  • Profit Margin: 8.32%

BIIB's fundamentals indicate a relatively high P/E ratio and a healthy profit margin. However, the debt-to-equity ratio and ROE may be areas of concern.

Current Market Position:

Current price: $215.43

Recent price action: The stock has been trading in a range with a recent uptrend.

Key support and resistance levels:

  • Support: $210.54 (from daily history)
  • Resistance: $222.15 (from daily history)

Technical Analysis:

Technical Indicators

RSI (14)
51.37
MACD
Bullish
50-day SMA
$209.33

SMA trends:

  • 5-day SMA: $216.80
  • 20-day SMA: $216.71
  • 50-day SMA: $209.33

The stock is currently trading above its 50-day SMA, indicating a bullish trend.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Bullish

Call vs Put dollar volume:

  • Call dollar volume: $1,908,780
  • Put dollar volume: $12,210

The options flow sentiment is strongly bullish, indicating a positive outlook for the stock.

Key Price Levels:

Support
$210.54
Resistance
$222.15

25-Day Price Forecast:

BIIB is projected for $217.11 to $224.92

Based on current technical trends, momentum, and indicators, the stock is expected to continue its uptrend.

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three recommended defined risk strategies:

  1. Bull Call Spread: Buy 1 BIIB 261016C00210000 (strike $210.0) and sell 1 BIIB 261016C00220000 (strike $220.0) @ $1.35 debit
  2. Iron Condor: Sell 1 BIIB 261016P00200000 (strike $200.0) and buy 1 BIIB 261016P00210000 (strike $210.0), sell 1 BIIB 261016C00220000 (strike $220.0) and buy 1 BIIB 261016C00230000 (strike $230.0) @ $2.56 credit
  3. Protective Put: Buy 1 BIIB 261016P00210000 (strike $210.0) @ $5.30 debit

These strategies align with the projected price range and offer a defined risk approach.

Summary: BIIB shows bullish momentum with strong institutional buying and improving technical indicators. The stock is expected to trade in a range with an upward bias.
View BIIB Options Chain

Risk Factors:

  • Technical warning signs: RSI and MACD indicate a potential pullback.
  • Sentiment divergences: None observed.
  • Volatility and ATR considerations: Recent volatility may increase.

These risk factors should be considered when evaluating the trade.

Overall Bias & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: Buy BIIB with a bullish bias and defined risk strategies.

Bull Call Spread 210 220 210-220 Bull Call Spread at Expiration Stock Price at Expiration Profit Loss

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.

Interactive charts load with JavaScript. This text is the crawlable summary.